October 2004, Vol 26, No. 10
Update Articles

Chemical pathology case conference - liver function tests

R W K Chiu 趙慧君, A Y W Chan 陳恩和, M H M Chan 陳浩明, C W Lam 林青雲, T W L Mak 麥永禮, A C C Shek 石志忠, M H L Tai 戴學良, S Tam 譚志輝

HK Pract 2004;26:430-435

Summary

Liver function tests are among the most frequently requested panels of clinical biochemistry tests. A liver function panel typically includes the assessment of plasma / serum total bilirubin, alkaline phosphatase, gamma-glutamyltransferase, alanine transaminase, aspartate transaminase, total protein and albumin. The main pitfall in the interpretation of liver function tests relates to the misconception that the individual test analytes are biologically specific to the hepatobiliary system. Although none of the analytes are absolutely specific for liver tissues, when they are considered collectively as a panel, particular patterns of abnormalities are indeed reflective of certain sub-groups of hepatobiliary pathologies. In this Case Conference, the biochemical profiles forming a series of clinical cases are used to illustrate the principles in the appropriate interpretation of the liver function tests.

摘要

肝功能是經常進行臨床生化的檢驗組別之一。一般的肝功能組別測試包括血漿或血清膽紅素,鹼性磷酸,γ谷氨轉移,丙氨酸轉氨,天門冬氨酸氨基轉移,總蛋白及白蛋白等項目。在詮釋肝功能化驗結果時的主要困難在於個別測試項目時被誤為肝膽系統所獨有。雖然個別項目的測試並非純與肝膽系統有關,但當將它們合併分析時,一些特別模式的轉變卻能夠反映某些肝膽病變的出現。

本個案討論利用一系列臨床病例的生化所見來說明正當理解肝功能測試結果的原理。


Introduction

This is the first of a new series, called Chemical Pathology Case Conference, which will become a quarterly feature of this journal. The Case Conferences will be contributed by the Chemical Pathologists from the Hong Kong College of Pathologists. Chemical pathology/clinical biochemistry tests are commonly requested for the diagnostic work-up of patients. When appropriately requested, sampled and interpreted, these test results are often very useful for the confirmation or exclusion of a clinical suspicion. On the other hand, misinterpretation of results may have drastic and irresolvable consequences. Furthermore, the frequent introductions of new tests and guidelines further complicate matters. Hence, with this Case Conference series, we are hoping to establish a forum for the discussion of skills involved in the interpretation of the commonly encountered clinical biochemistry results. In particular, the common pitfalls to avoid will be discussed. Each Case Conference will centre around one theme and clinical cases will be presented to illustrate key concepts. Let us start this series with "Liver function tests".

1.

 

Do liver function tests abnormalities reflect liver pathology on all occasions?

Liver function tests are among the most frequently requested panels of clinical biochemistry tests. The term "liver function tests" (LFT) usually refers to a profile of biochemical parameters which include: total bilirubin, alkaline phosphatase (ALP), gamma-glutamyltransferase (GGT), alanine transaminase (ALT), aspartate transaminase (AST), total protein and albumin. These parameters are customarily included into the collective term, LFT, because they are useful for the diagnosis of hepatobiliary pathology when considered collectively. Certain patterns of abnormalities are suggestive of particular hepatobiliary problem. However, the key to appropriate interpretation of the LFTs lies in the understanding that when considered individually, none of the members of the LFT panel is specific for liver pathology. For example, serum GGT could be elevated in the absence of liver pathology and be a consequence of liver enzyme induction by alcohol or anticonvulsants. Similarly, raised serum AST could be a result of acute myocardial infarction.

   
  Case 1
  A 75 year-old male complaining of haematuria.

 
Serum

 

       
Reference
interval
Total bilirubin  
12
   
< 15
ALP  
3200
 
U/L
 
40-100
GGT  
40
 
U/L
 
5-50
ALT  
53
 
U/L
 
< 58

   
 

What is the cause for the elevated serum ALP concentration?

What tests could be requested to confirm one's suspicion?

Rectal examination revealed a nodular prostate and x-ray revealed multiple osteosclerotic lesions suggestive of bony metastases. Prostate specific antigen (PSA) was markedly elevated. The patient was diagnosed to have prostate carcinoma.

There are several isoenzymes of ALP. They are present in liver, bone, intestine and placenta. Liver or bone pathologies are the most common causes of elevated serum ALP. ALP in the liver and GGT are found on the membranes of the bile canaliculi and ducts. Therefore, if a raised ALP is of liver origin, it indicates cholestasis and is usually associated with an elevated serum GGT. This patient had an isolated elevation in serum ALP in conjunction with the suggestive symptoms and signs of prostate carcinoma. Thus, the raised serum ALP is mostly a consequence of bony metastasis. If there is any doubt, ALP isoenzyme testing could be performed to distinguish between bone and liver origin of an elevated serum ALP.

   
  Case 2
  A 30 year-old healthy male attending routine check-up on two occasions. 

 
Serum

 

           
Reference
interval
Total bilirubin  
33
 
40
 
 
<15
Conjugated bilirubin  
8
 
10
 
   
ALT  
39
 
35
 
U/L
 
<58
GGT  
23
 
31
 
U/L
 
5-50
ALP  
80
 
82
 
U/L
 
25-95

   
 

What is the most likely diagnosis?

Plasma total bilirubin consists of conjugated and unconjugated forms. Unconjugated bilirubin is a metabolic by-product of haem metabolism. Thus, haemolytic disorders are associated with unconjugated hyperbilirubinaemia. Unconjugated bilirubin is normally conjugated by the liver to facilitate biliary excretion of bilirubin. Therefore, most liver pathologies are associated with conjugated hyperbilirubinaemia, except when there are enzymatic deficiencies in the bilirubin conjugation pathway. The illustrated case is one such condition, Gilbert's disease.

Gilbert's disease is a common benign condition which is more commonly seen in males and affects 1-5% of the population. Bilirubin levels typically are <50mmol/L and fluctuate with mild illness, infections and periods of starvation, leading to mild jaundice occasionally. Bilirubinuria (urine darkening on standing) is typically lacking, as bilirubinuria is a sign of conjugated hyperbilirubinaemia. When a haemolytic condition is excluded or unlikely, mild fluctuating unconjugated hyperbilirubinaemia is often due to Gilbert's disease.

   

2.

How do liver function tests reflect liver pathologies?

When considered collectively, certain patterns of the liver function tests reflect particular types of liver pathology. Such patterns can be broadly categorised as: (i) Hepatocellular pattern; (ii) Cholestatic pattern; and (iii) Mixed pattern of hepatocellular damage and cholestasis.

A hepatocellular pattern is associated with a predominant increase in serum ALT / AST but normal or only mildly elevated ALP / GGT. This is because both ALT and AST are intracellular enzymes in hepatocytes. Therefore, significant damage to hepatocytes results in the release of ALT and AST into the circulation. Causes of hepatocellular damage include: viral hepatitis, drugs (e.g. paracetamol), circulatory shock and liver congestion from cardiac failure.

A cholestatic pattern is associated with a predominant increase in serum ALP / GGT and conjugated bilirubin (partial biliary tree obstruction is an exception, see Case 5), with normal or only mild increase in ALT / AST. Both ALP and GGT are present on the membranes of bile canaliculi. Therefore, bile flow obstruction would result in induced production of GGT and increased release of ALP into the circulation. Causes of cholestasis / biliary obstruction include: gall stones, cholangitis, cholangiocarcinoma, carcinoma of the head of pancreas, liver metastasis, primary biliary cirrhosis, liver cirrhosis and drugs e.g. flucloxacillin, augmentin.

A mixed pattern is usually associated with raised ALT, AST, ALP, GGT and bilirubin. Such a pattern is often evident when the liver insult is prolonged. For example, prolonged biliary obstruction may lead to significant liver cell destruction (due to back pressure), and vice versa (acute hepatitis may give rise to severe cholestasis due to hepatic congestion).

Case 3
A 45 year-old woman had returned from a 2-week holiday in India and developed fever, rigors and sweats. The next day she developed nausea, anorexia, and right upper quadrant pain.


 
Date
Serum
  7th   8th   11th   13th   15th   17th       Reference
interval
Total protein   -   70   69   -   72   -   g/l   60-75
Albumin   -   -   33   29   -   27   g/l   35-50
Total bilirubin   42   51   70   168   268   304     <15
ALT   1665   3660   3710   1305   670   346   U/l   5-40
GGT   259   259   243   263   287   227   U/l   5-50
ALP   180   172   166   235   329   355   U/l   25-95

   
 

What is the most likely pathology?

What further test(s) could one request to determine the underlying cause?

Initially, the serum biochemical results revealed a marked elevation in ALT, gradual increase in serum bilirubin, with milder elevations in GGT and ALP. Therefore, this is suggestive of a hepatocellular condition with an acute time course, compatible with acute hepatitis. Viral serology was requested and hepatitis A IgM was positive and thus, the diagnosis was Hepatitis A. It can be noted that in the later stage of the disease, the liver function profile evolves into a mixed pattern. This is due to the development of a cholestatic component consequent to hepatic congestion and the progressive clearance of ALT.

Case 4
A 48 year-old woman with a past history of several episodes of recurrent right upper quadrant pain.


 
Serum           Reference
interval
Totalbilirubin   78   g/l   60-85
Albumin   39   g/l   30-50
ALP   620   U/l   30-120
ALT   55   U/l   <35
Total bilirubin   148     <15
Conjugated bilirubin   123      

   
 

What pathology does the biochemical profile suggest?

What investigation could be requested to determine the underlying cause?

The predominant elevations in ALP and conjugated bilirubin are compatible with biliary tree obstruction (cholestasis). Ultrasound of the hepatobiliary system indeed revealed the presence of several gall stones in the gall bladder.

Case 5
57 year-old woman had LFTs done during a follow-up visit 3 months after resection of a rectal carcinoma.


 
Serum           Reference
interval
Total protein   77   g/l   60-80
Albumin   38   g/l   35-52
Total bilirubin   14     <15
AST   32   U/l   5-40
GGT   308   U/l   5-50
ALP   570   U/l   30-120

   
 

What is the likely tissue source of the elevated serum ALP and why?

What is the most likely diagnosis?

Why is the bilirubin not elevated?

The elevated serum ALP is most likely to be derived from the liver as GGT is also elevated. Biliary tree obstruction leads to elevation of both ALP and GGT. The most likely diagnosis is liver metastases from the rectal carcinoma. Metastatic foci usually cause partial biliary tree obstruction. Drainage of bilirubin by the non-affected parts of the liver is adequate to maintain a normal serum total bilirubin concentration.

   

3.

What other information can be gained from the liver function tests?

Albumin is synthesised by the liver. Therefore, hypoalbuminaemia in association with liver

pathology is a marker reflective of the chronic nature of the illness. Besides the LFT panel of tests, there are other tests which are useful in the assessment of hepatic function.

Case 6
The following results are obtained from a 55 year-old man known to be a chronic hepatitis B carrier. On examination, spider naevi, petechiae, palmar erythema were found peripherally. The liver was nodular and palpable.


 
Serum           Reference
interval
Total protein   80   g/l   60-75
Albumin   25   g/l   35-52
Total bilirubin   55     <15
ALT   64   U/l   5-40
GGT   111   U/l   5-50
ALP   150   U/l   25-95

   
 

Is the biochemical profile typical for chronic liver disease?

What test would be useful for assessing the severity of the chronic liver disease?

If the patient presents with acute confusion and hepatic flap, what test would be requested?

As chronic liver disease develops insidiously with adequate opportunity for compensatory mechanisms to adapt, the biochemical profile is often normal except when in advanced stage, particularly when cirrhotic nodules obstruct biliary drainage. Hypoalbuminaemia is usually associated with chronic liver disease due both to reduced hepatic albumin synthesis and haemodilution consequent to generalised oedema. Prolongation of prothrombin time is often considered a marker reflective of the severity of the chronic liver disease as the clotting factors II, VII, IX and X are produced by the liver via a Vitamin K dependent pathway. However, Vitamin K deficiency due to fat malabsorption, for example due to biliary obstruction, could also result in prolongation of the prothrombin time. Plasma ammonia is measured in the assessment of hepatic encephalopathy as ammonia is normally detoxified by the liver and excreted as urea. The accumulation of ammonia in a patient with liver disease is a sign of hepatic failure.

Suggested reading

  1. Gopal DV, Rosen HR. Abnormal findings on liver function tests: interpreting results to narrow the diagnosis and establish a prognosis. Postgrad Med 2000;107:100-114.
  2. Walmsley RN, Watkinson LR, Cain HJ. Cases in chemical pathology: a diagnostic approach. 4th Ed. Singapore; World Scientific 1999;pp 287.

Key messages

  1. Liver function tests (LFTs) usually refer to a profile of biochemical parameters which include: total bilirubin, ALP, GGT, ALT, AST, total protein and albumin.
  2. When considered individually, none of the test analytes in the LFT profile are biologically specific to liver tissues. However, when considered collectively, certain patterns of LFT abnormalities are suggestive of particular sub-groups of hepatobiliary pathologies.
  3. Clinical conditions that result in the damage of hepatocytes are typically associated with a predominant increase in ALT / AST. Biliary obstruction is associated with a predominant elevation in ALP, GGT and conjugated bilirubin (except in partial biliary obstruction). When the hepatobiliary insult is prolonged, a mixed pattern (elevated ALT, AST, ALP, GGT and bilirubin) may ensue.
  4. Besides the LFTs, other tests, such as prothrombin time and plasma ammonia, are useful in the assessment of hepatobiliary pathologies.

R W K Chiu, MBBS(Queensland), PhD(CUHK), FRCPA
Associate Professor,
Department of Chemical Pathology, The Chinese University of Hong Kong.

A Y W Chan, MBChB(Glasg), MD(CUHK), FHKCP, FHKCPath
Consultant Chemical Pathologist,

Department of Pathology, Princess Margaret Hospital.

M H M Chan, MBChB(CUHK), FRCPA, FHKCPath, FHKAM(Pathology)
Deputising Senior Medical Officer,
Department of Chemical Pathology, Prince of Wales Hospital.

C W Lam, MBChB(CUHK), PhD(CUHK), FRCPA, FHKAM(Pathology)
Associate Professor,

Department of Chemical Pathology, The Chinese University of Hong Kong.

T W L Mak, MBChB(CUHK), MBA, FRCPA, FHKAM(Pathology)
Consultant,

Department of Clinical Pathology, Tuen Mun Hospital.

A C C Shek, MBBS(HK), FRCPath, FRCPA, FHKAM(Pathology)
Consultant,

Department of Pathology, Queen Elizabeth Hospital.

M H L Tai, BMedSc(CUHK), MBChB(CUHK), FRCPA
Medical Officer,
Department of Chemical Pathology, Prince of Wales Hospital.

S Tam, FRCP(Edin), FRCPA, FHKAM(Medicine), FHKAM(Pathology)
Head and Consultant,
Division of Clinical Biochemistry, Department of Pathology, Queen Mary Hospital.

Correspondence to : Prof R W K Chiu, of Wales Hospital, Shatin, N.T., Hong Kong.

E-mail: rossachiu@cuhk.edu.hk